Kenner C. Rice

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.

Peter J. Munson, Paolo Prolo, George P. Chrousos, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: the development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor.

G. Chrousos, C. Contoreggi, K. Rice, 2000, Bioorganic & medicinal chemistry letters.

Potential Uses of Corticotropin‐Releasing Hormone Antagonists

G. Chrousos, K. Rice, P. Gold, 2006, Annals of the New York Academy of Sciences.

Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.

G. Chrousos, S. Bornstein, D. Torpy, 1998, Endocrinology.

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.

G. Chrousos, J. Schulkin, M. Champoux, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs

G. Chrousos, E. Sternberg, K. Rice, 2002, Molecular Psychiatry.

A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep.

G. Chrousos, R. Smith, K. Rice, 1998, Endocrinology.